Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.19.1
Shareholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2019
Equity [Abstract]
Schedule of nonvested activity

Number of

Non-vested Shares

 Weighted Average Grant Date Fair Value
Non-vested, December 31, 2018 5,998,672 $ 0.61
Granted 200,000 -
Forfeited - -
Non-vested, March 31, 2019 6,198,672 $ 0.61
Schedule of stock option activities
Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic
Value
Balance Outstanding, December 31, 2018 11,445,698 $ 0.30
Granted - -
Exercised - -
Forfeited - -
Balance Outstanding, March 31, 2019 11,445,698 $ 0.30 6.42 $ 468,000
Exercisable, March 31, 2019 9,811,195 $ 0.30 6.08 $ 468,000
Schedule of warrant activities
Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic
Value
Balance Outstanding December 31, 2018 - $ - - $ -
Granted 1,000,000 0.18
Cancelled - -
Balance Outstanding March 31, 2019 1,000,000 $ 0.18 4.96 $ 0
Exercisable, March 31, 2019 200,000 $ 0.18 4.96 $ 0